Description
Peripheral neuropathy is a syndrome caused by many factors.
Mecobalamin is a peripheral nerve repair agent. Mecobalamin tablets are used to treat peripheral neuropathy and diseases caused by vitamin B12 deficiency by repairing damaged nerves, relieving pain and numbness, and alleviating sensory disturbances and movement abnormalities. Mecobalamin injection can be used to treat megaloblastic anemia.
Developed by Eisai Co., Ltd., Mecobalamin (trade name: Methycobal) was launched in Japan in the mid-1980s and introduced to China in 1996. Since 2003, several Chinese pharmaceutical companies have launched generic Mecobalamin products. Mecobalamin has been developing rapidly since it entered China, with its annual sales value increasing from less than CNY 200 million in 2005 to about CNY 609 million in 2017. There is huge demand for Mecobalamin in China. China's Mecobalamin market is dominated by Eisai China Inc., Eisai Co., Ltd., Jiangsu Sihuan Biopharmaceutical Co., Ltd., Nanjing Hailing Pharmaceutical Co., Ltd., North China Pharmaceutical Company Ltd., etc. In 2017, the market share by sales value of Eisai Co., Ltd. and its subsidiary Eisai China Inc. totaled about 70%.
It is expected that as the lifestyle changes and the population ages, and the incidences of peripheral neuropathy and megaloblastic anemia gradually increases, Mecobalamin will still have some growth potential in China.
Topics Covered:
- Indications for Mecobalamin
- Sales of Mecobalamin in China
- Competition on China's Mecobalamin market
- Major Mecobalamin manufacturers in China
- Prices of Mecobalamin in China from 2017 to 2018
- Major factors influencing the development of China's Mecobalamin market
- Prospect of China's Mecobalamin market from 2018 to 2022
Investigation Report on China's Mecobalamin Market, 2018-2022
Table of Contents
1 Relevant Concepts of Mecobalamin
1.1 Indications for Mecobalamin
1.2 Development of Mecobalamin in China
1.3 Governmental Approval of Mecobalamin in China
2 Sales of Mecobalamin in China, 2013-2017
2.1 Sales Value of Mecobalamin
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Mecobalamin
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Mecobalamin by Dosage Form in China, 2013-2017
2.3.1 Sales of Mecobalamin Tablets in China
2.3.2 Sales of Mecobalamin Capsules in China
2.3.3 Sales of Mecobalamin Injections in China
3 Analysis on Major Mecobalamin Manufacturers in China, 2013-2017
3.1 Analysis on Market Share of Major Mecobalamin Manufacturers
3.1.1 Market Share by Sales Value
3.1.2 Market Share by Sales Volume
3.2 Eisai China Inc.
3.2.1 Enterprise Profile
3.2.2 Sales of Eisai China Inc.'s Mecobalamin
3.3 Eisai Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Eisai Co., Ltd.'s Mecobalamin in China
3.4 Jiangsu Sihuan Biopharmaceutical Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of Jiangsu Sihuan Biopharmaceutical Co., Ltd.'s Mecobalamin in China
3.5 Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co., Ltd.
3.6 North China Pharmaceutical Company Ltd.
4 Prices of Mecobalamin in China, 2017-2018
4.1 Eisai China Inc. (Methycobal)
4.2 Eisai Co., Ltd. (Methycobal)
4.3 Jiangsu Sihuan Biopharmaceutical Co., Ltd. (Zhuohe)
4.4 Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co., Ltd. (Qixin)
4.5 North China Pharmaceutical Company Ltd. (Yishenbao)
5 Prospect of China's Mecobalamin Market, 2018-2022
5.1 Major Factors Influencing Development of China's Mecobalamin Market
5.1.1 Favorable Factors
5.1.2 Unfavorable Factors
5.1 Forecast on Market Size
5.2 Forecast on Market Trend
List of Charts
Chart Governmental Approval of Mecobalamin in China
Chart Sales Value of Mecobalamin in China, 2013-2017
Chart Sales Value of Mecobalamin in Parts of China, 2013-2017
Chart Sales Volume of Mecobalamin in China, 2013-2017
Chart Sales Volume of Mecobalamin in Parts of China, 2013-2017
Chart Sales Value of Mecobalamin Tablets in China, 2013-2017
Chart Sales Volume of Mecobalamin Tablets in China, 2013-2017
Chart Sales Value of Mecobalamin Capsules in China, 2013-2017
Chart Sales Value of Mecobalamin Injections in China, 2013-2017
Chart Market Share of Top 5 Mecobalamin Manufacturers by Sales Value in China, 2013-2017
Chart Market Share of Top 5 Mecobalamin Manufacturers by Sales Volume in China, 2013-2017
Chart Profile of Eisai China Inc.
Chart Sales Value of Eisai China Inc.'s Mecobalamin in China, 2013-2017
Chart Sales Volume of Eisai China Inc.'s Mecobalamin, 2013-2017
Chart Sales Value of Eisai Co., Ltd.'s Mecobalamin in China, 2013-2017
Chart Sales Volume of Eisai Co., Ltd.'s Mecobalamin in China, 2013-2017
Chart Sales Value of Jiangsu Sihuan Biopharmaceutical Co., Ltd.'s Mecobalamin, 2013-2017
Chart Sales Value of Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co., Ltd.'s Mecobalamin, 2013-2017
Chart Sales Value of North China Pharmaceutical Company Ltd.'s Mecobalamin, 2013-2017
Chart Prices of Eisai China Inc.'s Mecobalamin (Methycobal) in Parts of China, 2017-2018
Chart Prices of Eisai Co., Ltd.'s Mecobalamin (Methycobal) in Parts of China, 2017-2018
Chart Prices of Jiangsu Sihuan Biopharmaceutical Co., Ltd.'s Mecobalamin (Zhuohe) in Parts of China, 2017-2018
Chart Prices of Nanjing Hailing Pharmaceutical Co., Ltd.'s Mecobalamin (Qixin) in Parts of China, 2017-2018
Chart Prices of North China Pharmaceutical Company Ltd.'s Mecobalamin (Yishenbao) in Parts of China, 2017-2018
Chart Forecast on Sales Value of Mecobalamin in China, 2018-2022
Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 87
The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
Global Esomeprazole Magnesium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 74
The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030.
North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
Global Combination Therapy Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
Global Axitinib Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 68
The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
Global Lyme Disease Vaccine Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 70
The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi.
The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at......
Global Transdermal Absorption Patch Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
Global Ketoprofen Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis
The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
Global Methyl Salicylate Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 82
The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
Global Diclofenac Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
